arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ROCKWELL MEDICAL, INC.

RMTI
$7.26 ▼ -0.01 (-0.14%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

ROCKWELL MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $261.2M
Dividend Yield
Revenue Growth -31.8%
Op. Margin -6.8%
ROIC -10.2%
FCF / Share $-0.02
Trailing P/E
Price / Book 7.7x
FCF Yield
Debt / Equity 0.24
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$69.26M
↓ -31.8%
Net Income Profit after all expenses
$-5.31M
↓ -1007.1%
Operating Margin Operating profit as % of sales
-6.8%
↓ -1230.6% 18th
FCF / Share Free cash flow per share
$-0.02
↓ -113.5%
Long-Term Debt Long-term obligations
$8.83M
↑ +4.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
20
Returns
31
Financial Health
52
Cash Quality
27

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters